Written by Chrystal Moulton, Staff Writer. Treatment of malignant pleural mesothelioma with genetically engineered virus improves survival time by 18 months in Phase 1 trial. In a case study of a 68-year old male with malignant pleural mesothelioma (1), researchers...
Artichoke Leaf Extract in the Treatment of Pleural Mesothelioma
Written by Joyce Smith, BS. Treatment of malignant pleural mesothelioma cells with artichoke leaf extract significantly decreased cell growth and proliferation and increased apoptosis (cell death). There is presently no diagnostic tool that allows for early diagnosis...
Malignant Mesothelioma in the Young
Written by Joyce Smith, BS. This study compares the clinical characteristics of a young subset of mesothelioma patients to those who are older and generates survival times for both groups from the data. Malignant mesothelioma is an aggressive and often fatal cancer...
Malignant Pleural Mesothelioma: My Personal Story – Informed Opinion
Written by Elwood Richard, BS. A touching article by Elwood Richard, who developed malignant pleural mesothelioma from asbestos exposure as a young man. Recently I have been diagnosed with mesothelioma, a disease caused by exposure to asbestos. My only exposure was...
Potential Biomarkers for Malignant Mesothelioma (MM) in Asbestos Exposure and MM Patients
Written by Joyce Smith, BS. Study shows RANTES has the potential to be a critical biomarker for MM prognosis. Asbestos exposure and its association with mesothelioma is well documented. While Crocidolite asbestos is considered the asbestos type most pathogenic in the...
Possible Biomarker for Pleural Mesothelioma Found
Written by Chrystal Moulton, Staff Writer. Study shows B7-H1 could serve as a biomarker for early detection of malignant pleural mesothelioma. In the current research, B7 homolog 1 also known as programmed cell death ligand 1 (PDL-1) was tested on samples of patients...
Carotenoids in Breast Cancer Prevention
Written by Marcia J. Egles, MD. Study shows that higher total carotenoids were associated with 18-28% statistically lower risk of breast cancer. As recently reported in a large American study with twenty years of follow-up, women with high plasma carotenoids were at...
NGR-hTNF Treatment for Malignant Pleural Mesothelioma
Written by Joyce Smith, BS. NGR-hTNF has low toxicity and potential as a treatment for malignant pleural mesothelioma when used in combination with chemotherapeutic agents. Tumor necrosis factor (TNFα) is one of multiple proteins capable of inducing necrosis (death)...
Serum Survivin as a Biomarker for Malignant Mesothelioma
Written by Joyce Smith, BS. This study demonstrates that serum survivin can function as a useful biomarker in the treatment of malignant mesothelioma. Survivin is a member of a protein family that is involved in the regulation of both apoptosis (programmed cell death)...
Study Shows Benefit of Vegetarian Diet in Helping Protect against Colorectal Cancer
Written by Greg Arnold, DC, CSCS. Analyzed data on 77,659 participants in The Adventist Health Study 2 revealed that when compared to non-vegetarians, all those in the vegetarian groups had a 19% borderline statistically significant reduced risk of colon cancer and a...
Please follow & like us 🙂
